Related Experiment Video
Updated: May 20, 2026
08:52
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
New lessons learned from disease modeling with induced pluripotent stem cells
Tamer T Onder1, George Q Daley
1Stem Cell Transplantation Program, Division of Pediatric Hematology and Oncology, Manton Center for Orphan Disease Research, Howard Hughes Medical Institute, Children's Hospital Boston and Dana Farber Cancer Institute, Boston, MA, USA.
Current Opinion in Genetics & Development
|July 4, 2012
Summary
Induced pluripotent stem cells (iPSCs) offer patient-specific models for studying diseases. This technology helps identify disease pathways and screen for effective drugs by recapitulating disease phenotypes in vitro.
Area of Science:
- Biomedical research
- Stem cell biology
- Genetics
Background:
- Cellular reprogramming allows the generation of patient-specific induced pluripotent stem cells (iPSCs) from adult cells.
- iPSCs are valuable tools for disease modeling, enabling the study of various genetic disorders.
- Numerous iPSC lines have been established from patients with diverse conditions.
Purpose of the Study:
- To review the progress and limitations of using iPSCs for disease modeling.
- To highlight the potential of iPSCs in identifying disease-associated pathways.
- To discuss the application of iPSCs in in vitro drug screening for therapeutic development.
Main Methods:
- Generation of patient-specific induced pluripotent stem cells (iPSCs).
- Differentiation of iPSCs into disease-relevant cell types.
- Analysis of disease-specific phenotypes in differentiated cells.
Main Results:
- iPSCs successfully recapitulate disease-specific phenotypes in vitro.
- Reprogramming technology facilitates the identification of aberrant disease pathways.
- iPSC-derived cells serve as a platform for screening potential therapeutic drugs.
Conclusions:
- Induced pluripotent stem cell technology provides a powerful in vitro platform for disease modeling and drug discovery.
- Further advancements are needed to overcome existing limitations in iPSC applications for complex diseases.
- iPSCs hold significant promise for personalized medicine and the development of novel therapeutics.
Related Concept Videos
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...